Cardinal Health ranked 9th Greenest Company in the nation by NewsweekPosted by BioOhio on Jun. 11, 2014
Dublin, Ohio based Cardinal Health, long time BioOhio member, has been ranked as America’s 9th greenest company in Newsweek’s 2014 Green Rankings, released in partnership with Corporate Knights Capital, leading sustainability minds from nongovernmental organizations and the academic and accounting communities.
The study’s parameters included productivity in energy, carbon, water and waste, as well as the company’s reputation and sustainability outlook. Cardinal Health placed third in the Health Care sector, and ranked first among Ohio companies in the study. View the full report on Newsweek’s site, here.
BioOhio Summer Socials, bioscience networking at its best, this Wednesday in Cleveland at Market Garden Brewery!Posted by BioOhio on Jun. 09, 2014
BioOhio’s fun summer socials bring Ohio’s bioscience players together for networking, talking shop, and getting to know one another in a casual atmosphere. The event will be held from 4 to 6pm. Click here for details, location and registration information.
Complimentary hors d’oeuvres for all guests; 1 drink ticket for BioOhio members, and that includes employees of member organizations. Happy hour cash bar for non-members. Our social in Southwest Ohio on June 4th was a great success and we’re looking forward to Central Ohio on June 18th.
Prior to each BioOhio Summer Social, we will host an informational session titled “Services to Accelerate Growth and Increase $avings”
Taking place 2:45-3:45, this session will cover BioOhio services which address savings, efficiency, productivity and retention in the employee life cycle (talent, technology, training, together), as well as cover other useful money-saving member benefits. Content will be delivered by colleagues from Taylor Strategy Partners, Sequent, and BioOhio. Please notify Jen Goldsberry (email@example.com) if you plan to attend the info session.
Congressman David Joyce visits Neuros Medical for facility tour and discussionPosted by BioOhio on May. 29, 2014
As the Ohio affiliate of AdvaMed, BIO, MDMA and PhRMA, BioOhio participates in advocacy for issues that matter to our members. Many of our members are actively involved with their local, state and federal representatives.
Neuros is in the initial stages of their randomized, controlled pivotal clinical trial to evaluate the Company’s patented Altius® High Frequency Nerve Block System for the management of intractable limb pain of amputees.
The study consists of 130 patients at 15 medical centers in the U.S. When completed, the results will support a PreMarket Approval Application to FDA in order to market the device. The pivotal study builds upon their long-term pilot study which reported significant pain reduction. In addition, more than half of the subjects discontinued their pain medication use during the study.
“We were pleased and honored to welcome Representative Joyce to Neuros,” said Jon J. Snyder, President and CEO of Neuros Medical. “We appreciate his interest in our Altius System and the potential it holds for patients suffering from chronic pain.”
Representative Joyce was first elected in November 2012 and represents Ashtabula, Geauga, Lake and parts of Cuyahoga, Summit, Trumbull, and Portage counties.
Neuros Medical is focused on developing proprietary therapies for unmet needs to patients worldwide. The company’s patented platform technology, Electrical Nerve Block, is focused on the elimination of chronic pain in a variety of conditions including amputation pain, post-surgical pain, migraine, and trigeminal neuralgia.
BioOhio BioBulletin, May 2014Posted by BioOhio on May. 20, 2014
Welcome to the 5th edition of the BioOhio BioBulletin.
Trivia: Did you know that children grow fastest in the springtime?
This BioBulletin edition is again focused on events. Mark your calendars, share with colleagues, and register now! Event sponsorships are available at various levels, so commit early for more visibility.
My advice continues: Engage, Bring It!
|June 4 - BioOhio Summer Socials – Southwest Ohio at 50 West Brewing Company|
|June 11 – BioOhio Summer Socials – Northeast Ohio at Market Garden Brewery|
|June 18 – BioOhio Summer Socials – Central Ohio at Miller’s Columbus Ale House|
BioOhio’s fun summer socials bring Ohio’s bioscience players together for networking, talking shop, and getting to know one another in a casual atmosphere. Complimentary hors d’oeuvres for all guests, and members, the first drink is on us! Thanks to Taylor Strategy Partners for sponsor support! Additional sponsorship opportunities are available. Click on the links above to register. Those who attend all 3 will receive a special prize!
Prior to each BioOhio Summer Social, we will host an informational session titled “Services to Accelerate Growth and Increase $avings.” Taking place 2:45-3:45, this session will cover BioOhio services which address savings, efficiency, productivity and retention in the employee life cycle (talent, technology, training, together), as well as cover other useful money-saving member benefits. Content will be delivered by colleagues from Taylor Strategy Partners, Sequent, and BioOhio. Notify Jen Goldsberry (firstname.lastname@example.org) if you plan to attend the info session.
August 5 – Ohio Bioscience Expo & Showcase
Calling all Exhibitors! This event will be MD&M + BIO + AdvaMed + Pittcon + RS&A + MEDICA + HIMMS + ACRP + ASCO+++, all rolled into one. If you’re an established or start-up bioscience company, supplier, service provider, or innovator, you need to exhibit at this event. Exhibitors and attendees alike will connect with new customers, find new collaborators and partners, meet colleagues in the industry, and discover companies making cutting edge products and delivering quality services. Our previous expo had 86 exhibitors and we anticipate more this year. We have a super location in Aurora, located between Cleveland and Akron, at the stunning Bertram Inn & Conference Center. Book your exhibitor space now, and sponsorship opportunities are available.
Nationwide Children’s Hospital partners to form the Children’s Oncology Drug AlliancePosted by BioOhio on May. 08, 2014
Long time BioOhio member, Nationwide Children’s Hospital of Columbus, Ohio recently announced they have formed a research and development partnership with researchers and children’s cancer advocates in Australia to facilitate development of treatments for children fighting neuroblastoma, the most common and fatal form of solid cancer affecting infants. Currently there is no medicine approved to treat neuroblastoma, a cancer that affects up to 100 children in Australia and around 650 in the United States each year.
The Children’s Oncology Drug Alliance (CODA) unites the research and resources of the University of New South Wales (UNSW) in Australia and its commercialization arm, NewSouth Innovations; The Kids’ Cancer Project, an Australia-based childhood cancer research charity; and Novogen, an Australian oncology drug development company.